Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01159093 · ClinicalTrials.gov registry record · NA
Giving Immunizations Through Vaccine Education
A NA study of HPV Vaccines, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 23,675
- Enrollment target
- 1
- Study location
NCT01159093: Completed NA study of HPV Vaccines, sponsored by Children's Hospital of Philadelphia.
NCT01159093 is a NA study of HPV Vaccines that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 23,675 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1587% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01159093, a NA study of HPV Vaccines, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 23,675 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effectiveness of clinician-focused health IT-based decision support, family-focused health IT-based decision support, and a combination of both efforts, in increasing HPV and other adolescent vaccine rates among adolescent girls. We hypothesize that a combination of clinician-focused clinical decision support and family-focused decision support will be most effective.
Primary Outcome
The outcome will be assessed monthly, until study completion (1 year).
Conditions Studied
Interventions
- OTHER Control
- BEHAVIORAL Family Decision Support
- BEHAVIORAL Clinician Decision Support
- OTHER Family Decision Support and Clinician Decision Support
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,675 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT01159093 record still lists
NCT01159093 is an interventional study that assigns participants to a tested intervention. Its 23,675 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1587% higher).
The record links to 1 condition, with HPV Vaccines appearing as the primary indexed condition, and to 4 interventions - of which Control is the first listed.
NCT01159093 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01159093 about?
NCT01159093 is a clinical study titled "Giving Immunizations Through Vaccine Education". This study will test the effectiveness of clinician-focused health IT-based decision support, family-focused health IT-based decision support, and a combination of both efforts, in increasing HPV and other adolescent vaccine rates among adolescent girls. We hypothesize that a combination of clinicia...
What is the current status of trial NCT01159093?
This trial is currently completed. It is a NA study. The enrollment target is 23,675 participants. The study started on 2010-05. Estimated completion is 2011-05.
What conditions does trial NCT01159093 study?
This clinical trial studies the following conditions: HPV Vaccines.
What interventions are being tested in trial NCT01159093?
The interventions under investigation include: Control (OTHER), Family Decision Support (BEHAVIORAL), Clinician Decision Support (BEHAVIORAL), Family Decision Support and Clinician Decision Support (OTHER).
Who is sponsoring clinical trial NCT01159093?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01159093 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01159093's enrollment target sits among peer trials
23,675 10th of 2000 higher than 1,991 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06995898 · 24,000 participants · NA
The Vanguard Study: Testing a New Way to Screen for Cancer
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
- NCT06589310 · 25,000 participants
Falcon Real World Evidence Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia